Drug pricing policy in South Korea revised to ‘tiered pricing system’ Min Son of Hanol IP & Law describes how patent challenges have become even more important under the revised drug pricing framework in South Korea By Min Son April 14 2021
Drug patent expiry in 2021: Opportunities and challenges in the Korean market By Min Son January 12 2021
South Korea strengthens IP protection through legislative measures By Hyun-Sil Lee & Minji Ryan Kim August 20 2020
